Reckitt Benckiser’s Mead Johnson unit and Abbott Laboratories have been ordered to face a new trial in the US over ...

CEO Kris Licht said last week that Reckitt has received “interest” from prospective buyers for its nutrition unit housing ...

Reckitt Benckiser is moving forward with the sale of its nutrition operations housing the Mead Johnson infant-formula business. A deal for nutrition and Mead Johnson could potentially materialise ...

Missouri 22nd Judicial Circuit Court Judge Michael Noble granted the plaintiff's motion for a new trial on Thursday, citing ...

Reckitt has had a mixed year, with its stock falling sharply early on in 2024 over an internal investigation into its Middle ...

Reckitt has shown a medium-term uptrend since April 2024, outperforming peers, but litigation risks from Mead Johnson remain substantial, making the stock a hold. Reckitt's strategic focus on high ...

Reckitt and rival Abbott Laboratories are defending more than 1,000 lawsuits alleging a connection between their milk-based ...

Citi notes that Investing.com reported on Friday that the judge in the Whitfield infant formula case has overturned the October 31 verdict, ...

In March 2024, a U.S. court in Illinois awarded $60 million in damages to a mother of a baby that died from necrotizing ...

Reckitt Benckiser's shares hit an 11-year low in July but a turnaround strategy in the summer has seen it regain momentum ...

On Wednesday, Reckitt said its operating profit fell 4.2 per cent to £2.43billion last year, while revenue fell 3 per cent to ...

Reckitt Benckiser is continuing to assess options for its nutrition operations housing the Mead Johnson infant-formula business. After describing nutrition as “non-core” in July as part of a ...